Cholecalciferol 60,000 IU Nano Shots are a dedicated liquid pharmaceutical formulation containing the fat-soluble vitamin cholecalciferol (Vitamin D3) in a high-strength 60,000 IU presentation. The product format offers high-precision formulation in a compact liquid form around a revolutionary nano-shot liquid dosage delivery technology depending on the approved product formulation. The dosage-forms may be applicable to special formulations that require operational control over active-ingredient content, particle sizes or droplet size distribution, physical stability, and dose uniformity.
The formulation development of Cholecalciferol 60,000 IU Nano Shots must take into account the specific physicochemical characteristics of cholecalciferol as well as the characteristics of the nano-formulation system selected. Formulation scientists may investigate parameters such as the nature of dispersion, particle size distribution, formulation homogeneity, viscosity, storage stability, and compatibility with other ingredients or packaging materials.
For companies involved in formulation development of vitamin-based products, a new high technology product presentation such as the nano-shot can broaden the range of product presentations available within an existing portfolio. It can also be rolled out as a unique product in conjunction with a PCD Pharma Franchise network in a variety of complementary formulations such as tablets, capsules, syrups, drops, and other vitamin-based formulations.
The core active ingredient is Cholecalciferol 60,000 IU. As a pure fat-soluble vitamin, cholecalciferol will require an appropriate vehicle and excipient system to provide the desired dispersion characteristics in the liquid formulation.
The term "nano" describes a formulation utilizing minuscule dispersed structures or particles, often within the range of nanometers. The precise technology depends on the approved formulation and may include dispersing aids, emulsifiers, solubilizers, special manufacturing techniques, or particular excipients formulated to support nano-dispersion.
Potential ingredients might include a suitable pharmaceutical-grade base formulation such as liquids or suspensions, particular excipients to aid dispersion or improve stability, antioxidant compounds, excipients to support particle/droplet size reduction and distribution, or technologies such as surfactants or co-solvents formulated to act synergistically with the active ingredients.
Preformulating work can examine the compatibility of cholecalciferol with various excipients and Vehicles, to assess parameters such as solubility, droplet/particle size, ease of dispersion, sensitivity to temperature/humidity, stability, and interaction with other excipients.
Manufacture of a product such as Cholecalciferol 60,000 IU Nano Shots requires specialized formulation procedures and technology. The formulation typically involves the initial testing and validation of the pharmaceutical-grade ingredients to be used, with cholecalciferol being carefully dispensed due to its defined high-strength content.
The selection of system ingredients is prepared to a formal formula and used to prepare the base system in accordance with the validated manufacturing process. To achieve a nano-dispersion, specialized mixing or size-reduction technologies such as high shear, emulsification, and homogenization may be used during blending.
Process parameters are established in the formulation development stage to ensure that the resultant nano-structure provides the required physical and dispersive properties. Parameters include stirring or dispersing rates, dispersing times, fluid flow control, temperature control, and excipient addition rates.
It is also important to maintain a consistent large-batch system to avoid phase separation or sedimentation of particles or droplets if applicable, before moving into the unit-dose filling process. Agitation may be used if necessary to prevent severe phase separation, before filling into the designated container-closure system.
Due to the nature of the advanced formulation, quality control is important in ensuring that the finished article meets the desired specifications. Formulated products can be evaluated for appearance and certain physical parameters, as well as traditional methods such as assay and identity testing.
Assessment of the percentage of active material (cholecalciferol) with respect to the specified strength is very important. Product appearance, fill volume, pH, viscosity, and droplet size or particle size distribution may also be measured. The interaction between drug and excipient(s) may also be studied, especially when looking at the physical stability of the formulation.
The particle size distribution may be specified and the mean droplet size (or the particle size) assessed with respect to the distribution. This allows the formulation to be optimized and its physical stability, and dispersive characteristics confirmed. In-process controls include fill volume checks, mixing or dispersing homogeneity, and other production measures.
The finished product can be subjected to stability testing to monitor the product's behavior during storage. Quality procedures can measure the impact of storage conditions over time on the droplet sizes and physical appearance of the formulation.
The stability of formulations such as Cholecalciferol 60,000 IU Nano Shots can be assessed under controlled conditions to define the product's shelf life. The assay of the active ingredients, droplet or particle size, physical appearance, phase behavior, etc. are checked at intervals under specified storage conditions, taking into account the physical stability of the nano-structure.
Suitable packaging systems can be used to dispense the product as a nano-shots in small units such as single-dose packs, small bottles, ampoules, or other suitable vehicle. The closure system should be compatible with the formulation to prevent leakage or penetration of the environment.
Suitable labeling is provided to define the product name, potency, active ingredients, batch number, manufacturing date, storage conditions, expiry date, pack size, and pack form, quality assurance claims, and regulatory registration status. Single-dose systems offer a convenient presentation format to serve as a standardized dose as well as providing a flexible means for ready-to-use packaging.
Adding a new high-tech dosage presentation such as the nano-shot to a medicine product portfolio enhances the ability of a pharma company to offer differentiated formulations that stand out in the pharmaceutical market. By selecting the appropriate nano-container and providing a stable and effective formulation, a distinctive new presentation can be developed with focused manufacturing and quality-control measures.
For PCD Pharma Franchise operators, offering specific proprietary products using the latest formulation technologies is a natural step within their expanding portfolio, with a scientifically based presentation. A dedicated pharma franchise segment can include traditional formulations such as tablets and capsules, syrups, drops, and other present formulations, as well as new patent-pending formulas like this Cholecalciferol 60,000 IU nano-shot.
Development methodology begins with pre-formulation work, progressing through to individual batch formulation development, process validation, analytical testing, product packaging, and shelf life testing. Each step builds upon the previous one to develop a high-strength, stabilized, consistent formulation with a clearly defined identity.
In this way, a Cholecalciferol 60,000 IU Nano Shot product is developed to the correct specifications and formulated to deliver the benefits of a high-precision, targeted vitamin delivery system, with a neat single-dose presentation. From it, a stable and attractive product can be provided to the end-user.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech